Mizuho initiates coverage on NeuroPace with Outperform rating

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Mizuho analyst Anthony Petrone has initiated coverage on NeuroPace with an Outperform rating and a price target of $22.

powered bylight_fuzz_icon
46349715

*this image is generated using AI for illustrative purposes only.

Mizuho analyst Anthony Petrone has initiated coverage on NeuroPace with an Outperform rating and a price target of $22. The rating reflects a positive outlook on the company's performance.

Analyst Details

The coverage was initiated by Mizuho, targeting a price of $22 for NeuroPace shares.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors drove Mizuho's decision to set a $22 price target for NeuroPace?

How might NeuroPace's recent performance or pipeline developments support the Outperform rating?

What are the potential risks or challenges that could hinder NeuroPace from reaching the $22 target?

like15
dislike